Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
Actinium Pharmaceuticals |
734 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1112 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1212 |
|
|
|
|
| | | |
|
ADC Therapeutics |
736 |
|
|
|
|
| | | |
|
Allucent |
1384 |
|
|
|
|
| | | |
|
American Association for Cancer Research |
2103 |
|
|
|
|
|  |  |  |
|
American Society of Hematology |
1101 |
|
|
|
|
| | | |
|
Amgen |
MR Hall A1813 |
|
|
|
|
| | | |
|
Amgen |
451 |
|
|
|
|
| | | |
|
Ascentage Pharma |
2001 |
|
|
|
|
| | | |
|
Beckman Coulter Life Sciences |
100 |
|
|
|
|
| | | |
|
bluebird bio |
MR Hall A1514 |
|
|
|
|
| | | |
|
bluebird bio |
1261 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
721 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1307 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1407 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1506 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1607 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1707 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1308 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1408 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1507 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1608 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1708 |
|
|
|
|
| | | |
|
Cardinal Health |
577 |
|
|
|
|
| | | |
|
Catalyst Oncology |
167 |
|
|
|
|
| | | |
|
Children's Hospital of Philadelphia |
483 |
|
|
|
|
| | | |
|
CIBMTR (Center for International Blood & Marrow Transplant Research) |
782 |
|
|
|
|
| | | |
|
Cincinnati Childrens Hospital Medical Center |
2006 |
|
|
|
|
| | | |
|
Cleveland Clinic Taussig Cancer Institute |
770 |
|
|
|
|
| | | |
|
Cogent Biosciences |
728 |
|
|
|
|
| | | |
|
Curis, Inc. |
1965 |
|
|
|
|
| | | |
|
DAVA Oncology |
2155 |
|
|
|
|
| | | |
|
DAVA Oncology |
2157 |
|
|
|
|
| | | |
|
Eurofins Viracor |
161 |
|
|
|
|
| | | |
|
Foresight Diagnostics |
2165 |
|
|
|
|
| | | |
|
Fortrea |
372 |
|
|
|
|
| | | |
|
Foundation for Sickle Cell Disease Research |
132 |
|
|
|
|
| | | |
|
Fred Hutchinson Cancer Center |
1879 |
|
|
|
|
| | | |
|
Galapagos |
1681 |
|
|
|
|
| | | |
|
Genentech |
123 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1011 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1012 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1013 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1014 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
1301 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1309 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1409 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1508 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1609 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1310 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1410 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1509 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1610 |
|
|
|
|
| | | |
|
GSK |
1623 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1015 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1115 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1215 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1315 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1415 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1116 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1216 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1316 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1416 |
|
|
|
|
| | | |
|
Harvest Integrated Research Organization Corp. |
150 |
|
|
|
|
| | | |
|
HealthTree Foundation |
2016 |
|
|
|
|
| | | |
|
Imaging Endpoints II, LLC |
981 |
|
|
|
|
| | | |
|
Incyte Corporation |
425 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1807 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1907 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A2007 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1808 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1908 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A2008 |
|
|
|
|
| | | |
|
International Myeloma Foundation |
580 |
|
|
|
|
| | | |
|
International Myeloma Society |
1817 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
MR Hall A1312 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
467 |
|
|
|
|
| | | |
|
IQVIA Biotech |
681 |
|
|
|
|
| | | |
|
IQVIA Laboratories |
683 |
|
|
|
|
| | | |
|
John Theurer Cancer Center |
2149 |
|
|
|
|
| | | |
|
Legend Biotech |
401 |
|
|
|
|
| | | |
|
Machaon Diagnostics, Inc. |
475 |
|
|
|
|
| | | |
|
MD Anderson Cancer Center |
1711 |
|
|
|
|
| | | |
|
Mechatronics Instruments B.V. |
2079 |
|
|
|
|
| | | |
|
Med Learning Group |
1781 |
|
|
|
|
| | | |
|
Med Learning Group |
971 |
|
|
|
|
| | | |
|
Medpace Inc. |
2121 |
|
|
|
|
| | | |
|
Menarini Silicon Biosystems |
1775 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1911 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2011 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1912 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2012 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1913 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2013 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2112 |
|
|
|
|
| | | |
|
Merck & Co., Inc. |
201 |
|
|
|
|
| | | |
|
Mission Bio |
2129 |
|
|
|
|
| | | |
|
Moffitt Cancer Center |
2015 |
|
|
|
|
| | | |
|
National Comprehensive Cancer Network (NCCN) |
1801 |
|
|
|
|
| | | |
|
NeoGenomics |
1971 |
|
|
|
|
| | | |
|
Northside Hospital |
113 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
181 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
V100 |
|
|
|
|
| | | |
|
OHSU Knight Cancer Institute |
1809 |
|
|
|
|
| | | |
|
ONO PHARMA |
2063 |
|
|
|
|
| | | |
|
ONO PHARMA |
MR Hall A1113 |
|
|
|
|
| | | |
|
Ontada |
174 |
|
|
|
|
| | | |
|
Parexel |
260 |
|
|
|
|
| | | |
|
Precision for Medicine |
671 |
|
|
|
|
| | | |
|
Predicine |
156 |
|
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1111 |
|
|
|
|
| | | |
|
Prothena |
MR Hall A1111 |
|
|
|
|
| | | |
|
Prothena |
911 |
|
|
|
|
| | | |
|
PSI CRO |
1871 |
|
|
|
|
| | | |
|
Rutgers Cancer Institute/RWJBarnabas Health |
2113 |
|
|
|
|
| | | |
|
Sarah Cannon Research Institute |
1580 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1313 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1413 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
461 |
|
|
|
|
| | | |
|
SOBI, Inc |
1643 |
|
|
|
|
| | | |
|
SOBI, Inc |
MR Hall A2015 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1815 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1915 |
|
|
|
|
| | | |
|
St. Jude Children's Research Hospital |
1915 |
|
|
|
|
| | | |
|
Syneos Health |
619 |
|
|
|
|
| | | |
|
Tempus |
2108 |
|
|
|
|
| | | |
|
The MDS Foundation, Inc. |
1815 |
|
|
|
|
| | | |
|
United Porphyrias Association |
1911 |
|
|
|
|
| | | |
|
Worldwide Clinical Trials |
160 |
|
|
|
|
| | | |
|
Wuhan Kindstar Medical Laboratory Limited Company |
1181 |
|
|
|
|
| | | |
|
X4 Pharmaceuticals |
730 |
|
|
|
|
| | | |